Most just lately, it's been identified that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in very similar places as classical opioid receptors, it binds to some big selection of endogenous opioids. Contrary to most opioid receptors, this receptor acts being a scavenger and does not act